Rare diseases
Investigational molecules
Locations
Back to Slovakia68 clinical trials in Bardejov, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years
SlovakiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SlovakiaStudy on the Long-Term Safety of Brivaracetam for Children and Young Adults with Childhood or Juvenile Absence Epilepsy
SlovakiaStudy on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough
SlovakiaStudy on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy
SlovakiaStudy on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease
SlovakiaStudy on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis
SlovakiaStudy on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines
SlovakiaStudy of XXB750 and Drug Combination for Patients with Heart Failure
SlovakiaStudy on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma
SlovakiaStudy on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma
SlovakiaStudy on Eptinezumab for Preventing Chronic Migraine in Adults
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Research focusing on cardiovascular diseases and treatments, including studies on hypertriglyceridemia and stroke prevention. Multiple trials are investigating innovative therapies for atherosclerotic cardiovascular disease and heart failure.
Novel approaches include testing medications like pelacarsen and obicetrapib for cardiovascular event reduction.
Comprehensive studies addressing respiratory conditions, with particular focus on asthma and COPD management. Research includes evaluation of new inhaler formulations and treatments.
Trials are evaluating both established and innovative treatment combinations for optimal patient outcomes.
Investigation of treatments for various neurological conditions, including epilepsy and depression. Studies focus on both pediatric and adult populations.
Current research includes evaluating cenobamate for seizure control and new approaches for major depressive disorder.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
